The International Conference on Pharmaceutical Innovation and Development 2023 Kicked off in Yantai
PR100236
YANTAI, China, July 19, 2023 /Xinhua=KYODO JBN/--
On the morning of July 13, the International Conference on Pharmaceutical
Innovation and Development 2023 kicked off in Yantai. The conference was hosted
by the People's Government of Shandong Province, co-sponsored by the Chinese
Pharmaceutical Association, the China Pharmaceutical Innovation and Research
Development Association (PhIRDA), the China Society for Drug Regulation and the
Shandong Administration for Market Regulation and co-organized by the People's
Government of Yantai and the Shandong Administration for Market Regulation,
with the theme of "Innovation Leading the High-quality Development", with an
aim to build a platform for cooperation and exchange and invite all circles to
join the Yantai "industrial chain partnership" of biomedicine.
At the opening ceremony, the government of Yantai issued the award certificates
to the innovative medical products manufacturers that met the industrial
support policy in 2022, with a total bonus of 136 million Chinese yuan. Five
innovative institutions and the first batch of health and medicine development
sub-funds of Yantai were established, including the Institute of Life Science
and Medical Health, the Yantai Innovation Institute of Stem Cells and
Regenerative Medicine, the National Key Laboratory of Luye Pharma Advanced Drug
Delivery System, the Dongcheng Pharmaceutical National Enterprise Technology
Center and Yantai Biomedicine Industry and Education Integration Community. A
signing ceremony was held for 35 key projects with a total investment of 17.2
billion Chinese yuan.
In recent years, Yantai has taken different moves around the aim to build a
demonstrative city for international life science innovation and accelerate its
pace to create new fertile soil for the growth of biomedicine industry, a new
highland for innovation and creativity and a new blue ocean for capital
pooling. Yantai will also include the biomedicine industry into its "9+N"
manufacture clustering and cultivation project and concentrate on setting up
examples to achieve a new leap in its industrial ecology, take new steps
towards industrial park construction, achieve a new speed in pharmaceutical
development and new improvements in the guarantee of elements.
Source: Yantai Administration for Market Regulation
Image Attachments Links:
Link: https://iop.asianetnews.net/view-attachment?attach-id=441604
Caption: The International Conference on Pharmaceutical Innovation and Development 2023
kicked off in Yantai.
Link: https://iop.asianetnews.net/view-attachment?attach-id=441609
Caption: The International Conference on Pharmaceutical Innovation and Development 2023
kicked off in Yantai.
Link: https://iop.asianetnews.net/view-attachment?attach-id=441610
Caption: The International Conference on Pharmaceutical Innovation and Development 2023
kicked off in Yantai.
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。